Susquehanna International Group, LLP Tarsus Pharmaceuticals, Inc. Put Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$25.17 - $38.73 $5.77 Million - $8.87 Million
229,100 Added 1316.67%
246,500 $6.7 Million
Q1 2024

May 07, 2024
BUY
$19.61 - $39.22 $52,947 - $105,894
2,700 Added 18.37%
17,400 $632,000
Q4 2023

Feb 14, 2024
SELL
$12.98 - $20.73 $19,470 - $31,095
-1,500 Reduced 9.26%
14,700 $297,000
Q3 2023

Nov 14, 2023
BUY
$14.75 - $24.62 $238,950 - $398,844
16,200 New
16,200 $287,000

Others Institutions Holding TARS

# of Institutions
170
Shares Held
43.3M
Call Options Held
484K
Put Options Held
4.1K
View Full List

About Tarsus Pharmaceuticals, Inc.

TARS Quotes by TradingView
  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.41B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email